Vanguard Fiduciary Trust
TNXP icon

Vanguard Fiduciary Trust’s Tonix Pharmaceuticals TNXP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
102,054
+17,784
+21% +$229K ﹤0.01% 2907
2026
Q1 		$1.16M Buy
+84,270
New +$1.3M ﹤0.01% 2847

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's TNXP Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Tonix Pharmaceuticals (TNXP) stake by 21% in Q2 2026, buying an estimated $229K and bringing the position to 102,054 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Vanguard Fiduciary Trust first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Vanguard Fiduciary Trust held 102,054 shares of Tonix Pharmaceuticals worth $1.3M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 17,784 Tonix Pharmaceuticals shares in Q2 2026, an estimated $229K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2907 holding.
  • Vanguard Fiduciary Trust first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.